Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Schwarzkopf (Neuherberg, Germany), S. Witt (Neuherberg, Germany), J. Wälscher (Heidelberg, Germany), M. Kreuter (Heidelberg, Germany). Longitudinal cost of care in individuals with different subtypes of interstitial lung diseases. 4732

Member's Comments

No comment yet.

Related content which might interest you: Interims analysis of the EXCITING-ILD registry (registry for exploring clinical and epidemiological characteristics of interstitial lung diseases) Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Prevalence and characteristics of cystic lung lesions in children with interstitial lung diseases – a register-based study Source: Virtual Congress 2021 – Paediatric bronchology Year: 2021 Intensive care outcomes in patients with diffuse fibrotic parenchymal lung diseases Source: Annual Congress 2011 - Intensive care outcome Year: 2011 Benefits from a program for “early interstitial lung diseases” in primary care centers Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases Year: 2017 Health care resources utilisation and costs in patients with non-IPF progressive fibrosing interstitial lung disease Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018 EPIDIA: an App to to assist physicians in the care of patients with interstitial lung diseases Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia Year: 2021 The management of children with interstitial lung disease Source: International Congress 2018 – Difficult paediatric lung disease Year: 2018 The effectiveness of pulmonary rehabilitation in interstitial lung diseases in terms of functional markers Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018 Epidemiological profile of chronic interstitial lung diseases in Tunisian patients Source: International Congress 2017 – ILDs: clinical problems Year: 2017 The internet-based network for the management of children with interstitial lung disease Source: International Congress 2014 – PG01 Challenges faced when diagnosing idiopathic interstitial lung disease Year: 2014 Medication for childhood interstitial lung diseases differs internationally Source: International Congress 2018 – Orphan diseases in children Year: 2018 Associations between comorbidities and survival in patients with interstitial lung diseases Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases Year: 2021 A comparison of existing questionnaires for identifying the causes of interstitial and rare lung diseases Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases Year: 2019 Genetic studies in paediatric interstitial lung disease Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease Year: 2012 The future of treatment for interstitial lung diseases: the patient’s and physician’s perspective Source: International Congress 2019 – Rare lung diseases Year: 2019 Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases – a claims data analysis Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments Year: 2018 Quality of life in patients of interstitial lung diseases from India Source: Eur Respir J 2005; 26: Suppl. 49, 540s Year: 2005 Air travel for patients with interstitial lung diseases Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009 Why should we care for the vessels in interstitial lung disease? Source: Virtual Congress 2020 – European Reference Network for rare lung diseases (ERN-LUNG): acting for improved cross-border management of rare diseases Year: 2020 Progressive fibrosing interstitial lung diseases (PF-ILDs): prevalence and characterization in two Italian referral centers Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020